These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 18598093)

  • 1. Effect of repeated doses of darunavir plus low-dose ritonavir on the pharmacokinetics of sildenafil in healthy male subjects: phase I randomized, open-label, two-way crossover study.
    Sekar V; Lefebvre E; De Marez T; De Pauw M; De Paepe E; Vangeneugden T; Hoetelmans RM
    Clin Drug Investig; 2008; 28(8):479-85. PubMed ID: 18598093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and safety of ambrisentan in combination with sildenafil in healthy volunteers.
    Spence R; Mandagere A; Dufton C; Venitz J
    J Clin Pharmacol; 2008 Dec; 48(12):1451-9. PubMed ID: 18832294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir.
    Muirhead GJ; Wulff MB; Fielding A; Kleinermans D; Buss N
    Br J Clin Pharmacol; 2000 Aug; 50(2):99-107. PubMed ID: 10930961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects.
    Sidharta PN; van Giersbergen PL; Wolzt M; Dingemanse J
    Br J Clin Pharmacol; 2014 Nov; 78(5):1035-42. PubMed ID: 24962473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers.
    Schöller-Gyüre M; Kakuda TN; Sekar V; Woodfall B; De Smedt G; Lefebvre E; Peeters M; Hoetelmans RM
    Antivir Ther; 2007; 12(5):789-96. PubMed ID: 17713162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioequivalence of sildenafil granules and sildenafil tablets in Korean healthy volunteers.
    Zheng R; Kim BH
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):530-6. PubMed ID: 24786017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of darunavir/ritonavir and rifabutin coadministered in HIV-negative healthy volunteers.
    Sekar V; Lavreys L; Van de Casteele T; Berckmans C; Spinosa-Guzman S; Vangeneugden T; De Pauw M; Hoetelmans R
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4440-5. PubMed ID: 20660678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between ethinyl estradiol, norethindrone and darunavir with low-dose ritonavir in healthy women.
    Sekar VJ; Lefebvre E; Guzman SS; Felicione E; De Pauw M; Vangeneugden T; Hoetelmans RM
    Antivir Ther; 2008; 13(4):563-9. PubMed ID: 18672535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers.
    Muirhead GJ; Faulkner S; Harness JA; Taubel J
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):37S-43S. PubMed ID: 11879258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
    Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
    Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants.
    Moore K; Thakkar N; Magee M; Sevinsky H; Vakkalagadda B; Lubin S; Llamoso C; Ackerman P
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0225121. PubMed ID: 35315687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction between nevirapine and darunavir with low-dose ritonavir in HIV-1-infected patients.
    Sekar V; Lefebvre E; Mariën K; De Pauw M; Vangeneugden T; Pozniak A; Hoetelmans RM
    Br J Clin Pharmacol; 2009 Jul; 68(1):116-9. PubMed ID: 19660009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic comparison of an orally disintegrating film formulation with a film-coated tablet formulation of sildenafil in healthy Korean subjects: a randomized, open-label, single-dose, 2-period crossover study.
    Roh H; Son H; Lee D; Yeon KJ; Kim HS; Kim H; Park K
    Clin Ther; 2013 Mar; 35(3):205-14. PubMed ID: 23497759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality.
    Nichols DJ; Muirhead GJ; Harness JA
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):5S-12S. PubMed ID: 11879254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks.
    Aberg JA; Tebas P; Overton ET; Gupta SK; Sax PE; Landay A; Falcon R; Ryan R; De La Rosa G
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1184-95. PubMed ID: 22352336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic study of dual therapy with raltegravir 400 mg twice daily and Darunavir/Ritonavir 800/100 mg once daily in HIV-1-infected patients.
    Martínez-Rebollar M; Muñoz A; Pérez I; Hidalgo S; Brunet M; Laguno M; González A; Calvo M; Loncà M; Blanco JL; Martínez E; Gatell JM; Mallolas J
    Ther Drug Monit; 2013 Aug; 35(4):552-6. PubMed ID: 23851911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of pummelo juice on pharmacokinetics of sildenafil in healthy adult male Jordanian volunteers.
    Al-Ghazawi MA; Tutunji MS; AbuRuz SM
    Eur J Clin Pharmacol; 2010 Feb; 66(2):159-63. PubMed ID: 19830413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of a new orally soluble film formulation of sildenafil administered without water.
    Kim EY; Lee SY; Jeon JY; Im YJ; Kim Y; Kim HI; Shin KS; Park SJ; Seo YH; Lee JY; Park JK; Chae SW; Kim MG
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):437-45. PubMed ID: 24786013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of sildenafil and indinavir when co-administered to HIV-positive patients.
    Merry C; Barry MG; Ryan M; Tjia JF; Hennessy M; Eagling VA; Mulcahy F; Back DJ
    AIDS; 1999 Oct; 13(15):F101-7. PubMed ID: 10546851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interaction between indinavir and darunavir with low-dose ritonavir in healthy volunteers.
    Sekar V; Lefebvre E; De Marez T; De Pauw M; De Paepe E; Vangeneugden T; Hoetelmans RM
    Intervirology; 2010; 53(3):176-82. PubMed ID: 20197684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.